CRIP1 and gastric cancer: This finding was corroborated by the results of plasmid-based HR repair reporter assays, which revealed that the CRIP1 silencing in GC cells significantly decreased (>60% for AGS and BGC823) the percentage of green fluorescent protein (GFP)-positive cells upon I-SceI expression (Fig. 3B).